No Vitamin D Deficiency in Patients with Parkinson’s Disease

Figures & data

Table 1 Scored Clinical Characteristics of PD Patients

	Mean	SD	Minimum	Maximum
UPDRS I–IV	40.95	20.44	6	104
UPDRS I	3.08	2.99	0	12
UPDRS II	14.40	8.27	2	42
UPDRS III	19.40	11.57	2	56
UPDRS IV	4.07	4.03	0	19
MOCA	20.68	5.58	8	30

Note: All data are given as mean±standard deviation (SD).

Abbreviations: MOCA, Montreal Cognitive Assessment; UPDRS I, Unified Parkinson’s Disease Rating Scale mental behavior; UPDRS II, Unified Parkinson’s Disease Rating Scale activities of daily living; UPDRS III, Unified Parkinson’s Disease Rating Scale motor examination; UPDRS IV, Unified Parkinson’s Disease Rating Scale motor complications; UPDRS I–IV, total UPDRS score.

Table 2 Correlation Analysis Between 25-(OH)-Vitamin D Blood Concentrations and Clinical Parameters

Variable 1	Variable 2	R	p
25-(OH)-vitamin D	UPDRS	−0.056	ns
25-(OH)-vitamin D	UPDRS I	−0.054	ns
25-(OH)-vitamin D	UPDRS II	−0.08	ns
25-(OH)-vitamin D	UPDRS III	−0.012	ns
25-(OH)-vitamin D	UPDRS IV	0.087	ns
25-(OH)-vitamin D	MOCA	−0.027	ns

Abbreviations: R, correlation coefficient; p, p-value.

Figure 1 25-(OH)-vitamin D blood concentrations.

Abbreviations: CO, Controls; PD, Parkinson’s disease patients, -, mean value.